{"@context":["https://w3id.org/dats/context/sdo/dataset_sdo_context.jsonld","http://w3id.org/dats/context/obo/dataset_obo_context.jsonld"],"@type":"Project","acronym":"Ebola+","description":"Ebola and other filoviral haemorrhagic fevers. Umbrella programme comprising the IMI projects EBOVAC1, EBOVAC2, EBOVAC3, VSV-EBOVAC, VSV-EBOPLUS, PEVIA, EBOMAN, EBODAC, Mofina, FILODIAG, EbolaMoDRAD and VHFMoDRAD.","extraProperties":[{"@type":"CategoryValuesPair","category":"projectAcronym","values":[{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"Ebola+"}]}],"fundedBy":[{"@context":"https://w3id.org/dats/context/sdo/grant_sdo_context.jsonld","@type":"Grant","name":"IMI2 (Grant number )"}],"identifier":{"@context":"https://w3id.org/dats/context/sdo/identifier_info_sdo_context.jsonld","@type":"Identifier","identifier":"f7a69d98-5f11-11eb-917b-acde48001122"},"keywords":[{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"IMI projects"},{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"Infectious diseases"},{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"Ebola and related diseases"},{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"Vaccines"},{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"Diagnostics"},{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"Ebola+"},{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"Manufacturing technologies"}],"projectAssets":[],"projectLeads":[],"title":"Ebola+","types":[{"@context":"https://w3id.org/dats/context/sdo/annotation_sdo_context.jsonld","@type":"Annotation","value":"IMI projects"}]}